Alignment Healthcare Reports 31% Year-Over-Year Membership Growth to 275,300 as of Jan. 1, 2026
Rhea-AI Summary
Alignment Healthcare (NASDAQ: ALHC) reported Jan. 1, 2026 health plan membership of approximately 275,300, a 31% year-over-year increase after a strong AEP and a ~30% compounded annual membership growth since its 2021 IPO. The company guides year-end 2026 membership of 290,000 to 296,000 (about 24%–27% growth vs. the midpoint of prior guidance) and expects consensus adjusted EBITDA ≈ $145 million for 2026 to fall within its full-year guidance range. The company reaffirmed its full-year 2025 guidance for membership, revenue, adjusted gross profit and adjusted EBITDA and noted timing for full 2026 guidance at its Q4 2025 earnings call.
Positive
- Membership 275,300 as of Jan 1, 2026 (+31% YoY)
- 5-year CAGR ~30% in membership since 2021 IPO
- Year-end 2026 membership guidance of 290k–296k (≈24%–27% growth)
- Consensus adjusted EBITDA ≈ $145M expected to be within 2026 guidance
Negative
- Company uses non-GAAP measures and cannot reconcile estimated adjusted gross profit and adjusted EBITDA ranges to GAAP net loss
- Full-year 2026 guidance details not provided until the Q4 2025 earnings call
News Market Reaction
On the day this news was published, ALHC gained 2.41%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
ALHC is down 0.81% while several peers like OSCR, PGNY, MOH and CVS also show declines, but CLOV is up, and only OSCR appears in the momentum scanner, pointing to a mixed, stock‑specific backdrop rather than a clear sector‑wide move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 17 | Conference presentation | Neutral | +2.6% | Announcement of J.P. Morgan Healthcare Conference presentation and webcast access. |
| Nov 19 | Conference presentation | Neutral | +1.4% | Piper Sandler conference presentation with webcast and replay details. |
| Oct 30 | Earnings beat | Positive | -6.0% | Q3 2025 results exceeded guidance with strong revenue and membership growth. |
| Oct 22 | Quality accolades | Positive | -0.7% | Named 2026 Best Insurance Company for Medicare Advantage across all markets. |
| Oct 21 | Strategic partnership | Positive | +0.7% | Partnership with Suvida Healthcare to expand bilingual primary care in Arizona. |
The stock has sometimes sold off on strong fundamental news, with prior earnings and quality accolades seeing negative or muted next-day reactions despite positive business updates.
Over the last few months, ALHC has reported strong fundamentals, including Q3 2025 results that surpassed the high end of guidance across key metrics and highlighted 100% of members in plans rated 4 stars or higher. It also received multiple Medicare Advantage quality accolades and expanded bilingual care access in Arizona. Conference presentation announcements in November and December saw modest positive reactions. Against this backdrop, today’s update on membership growth and 2026 expectations extends a pattern of operational momentum.
Market Pulse Summary
This announcement highlights continued scale and quality, with health plan membership reaching 275,300 members, up 31% year over year, and a compounded growth rate of about 30% since the 2021 IPO. The company guides to 290,000–296,000 members by year-end 2026 and expects consensus adjusted EBITDA of $145 million to sit within its 2026 range while reaffirming 2025 guidance. Maintaining 100% of members in 4‑star‑plus plans remains a key quality and competitiveness metric to watch.
Key Terms
medicare advantage medical
non-gaap financial
adjusted ebidta financial
centers for medicare & medicaid services regulatory
star ratings regulatory
equity-based compensation financial
right of use ("rou") assets financial
AI-generated analysis. Not financial advice.
- Guides year-end 2026 health plan membership range of 290,000 to 296,000.
- Announces its expectation that consensus adjusted EBITDA of approximately
$145 million in 2026 will be within its full-year 2026 guidance range. - Reaffirms its full-year 2025 guidance ranges on health plan membership, revenue, adjusted gross profit and adjusted EBITDA.
ORANGE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), an award-winning Medicare Advantage (MA) company, today announced Jan. 1 health plan membership of approximately 275,300, representing
Following its AEP results, the company expects to have health plan membership of 290,000 to 296,000 at year-end 2026, representing growth of approximately
Lastly, the company is reaffirming its full-year 2025 guidance ranges on health plan membership, revenue, adjusted gross profit and adjusted EBITDA provided Oct. 30, 2025.
“Alignment Healthcare continues to set the bar high for Medicare Advantage done right,” said John Kao, founder and CEO, Alignment Healthcare. “As we mark five years as a public company, we are proving strong business performance comes from delivering on our promise to seniors: better care, better outcomes and lower costs. The strength of our model is driving industry-leading performance in MA today and positions us for scalable, repeatable growth.”
Alignment’s proven care-centered model continues to deliver high-quality outcomes and create shareholder value by serving seniors. Based on Centers for Medicare & Medicaid Services star ratings,
Non-GAAP Measures
Adjusted gross profit is a non-GAAP financial measure that is presented as supplemental disclosure, that we define as income (loss) from operations before depreciation and amortization, clinical equity-based compensation expense, clinical restructuring costs and selling, general, and administrative expenses. We cannot reconcile our estimated ranges for adjusted gross profit to loss from operations, the most directly comparable GAAP measure, and cannot provide estimated ranges for loss from operations, without unreasonable efforts because of the uncertainty around certain items that may impact loss from operations, including equity-based compensation expense and depreciation and amortization, that are not within our control or cannot be reasonably predicted.
Adjusted EBITDA is a non-GAAP financial measure that is presented as supplemental disclosure, that we define as net income (loss) before interest expense, income taxes, depreciation and amortization expense, acquisition expenses, certain litigation costs, gains or losses on right of use ("ROU") assets, gains or losses on sale of property and equipment, restructuring costs and equity-based compensation expense. We cannot reconcile our estimated ranges for Adjusted EBITDA to net loss, the most directly comparable GAAP measure, and cannot provide estimated ranges for net loss, without unreasonable efforts because of the uncertainty around certain items that may impact net loss, including equity-based compensation expense and depreciation and amortization, that are not within our control or cannot be reasonably predicted.
About Alignment Healthcare
Alignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ: ALHC), Alignment Health’s mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage members every day. Based in California, the company partners with nationally recognized and trusted local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, AVA®. As it expands its offerings and grows its national footprint, Alignment upholds its core values of leading with a serving heart and putting the senior first. For more information, visit www.alignmenthealth.com.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding our future growth and our financial outlook for the year ended December 31, 2025. Forward-looking statements are subject to risks and uncertainties and are based on assumptions that may prove to be inaccurate, which could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our ability to attract new members and enter new markets, including the need for certain governmental approvals; our ability to maintain a high rating for our plans on the Five Star Quality Rating System; our ability to develop and maintain satisfactory relationships with care providers that service our members; risks associated with being a government contractor, including potential federal reductions in MA funding; changes in laws and regulations applicable to our business model; risks related to our indebtedness; changes in market or industry conditions and receptivity to our technology and services; results of litigation or a security incident; and the impact of shortages of qualified personnel and related increases in our labor costs. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our Annual Report on Form 10-K for the year ended December 31, 2024, and the other periodic reports we file with the SEC. All information provided in this release is as of the date hereof, and we undertake no duty to update or revise this information unless required by law.
Investor Contact
Harrison Zhuo
hzhuo@ahcusa.com
Media Contact
Priya Shah
mPR, Inc. for Alignment Health
alignment@mpublicrelations.com